In this issue:
2025 CDC guideline for injectable lenacapavir as HIV PrEP
Substance use & ART adherence/symptom outcomes
REPRIEVE: sudden cardiac death & undetermined death in PLHIV
Rapid-start bictegravir/emtricitabine/tenofovir alafenamide in newly diagnosed HIV-1
Perspectives on LA-ART regimens among PLHIV & healthcare professionals
Community-based HIV services for youth in Zimbabwe
Disability among PLHIV in Asia
Guidelines on HIV & breastfeeding in Europe
US HIV testing trends in high-risk women
Global HIV-related mortality in children/adolescents on ART
Please login below to download this issue (PDF)